Professional Summary

Professional Overview

Reimar Schlingensiepen is an experienced life sciences executive with a proven track record of driving innovation and leading successful business development initiatives. As the Chief Executive Officer of AudioCure Pharma GmbH and Themeos Interim Management and Business Development, he leverages his extensive industry expertise to guide companies through strategic transformations and foster collaborative partnerships.

Experience Summary

Current Role

As the CEO of AudioCure Pharma GmbH since 2017, Reimar has been instrumental in advancing the company's pipeline of novel therapeutics for the treatment of hearing disorders. Under his leadership, AudioCure has secured significant funding and formed strategic alliances to accelerate the development and commercialization of its innovative solutions. Reimar also serves as the CEO of Themeos Interim Management and Business Development, where he provides expert advisory and interim management services to support the growth and optimization of life sciences organizations.

Career Progression

Prior to his current roles, Reimar held various senior-level positions, including Chief Operating Officer at AudioCure Pharma GmbH, Senior Advisor for Business Development Europe at GRI Bio, Inc., and Head of Business Development and Strategy at Pentracor GmbH. He has also garnered extensive experience in interim management and business development, having held roles at JADO Technologies GmbH and cerboMed GmbH. Earlier in his career, Reimar served as the Chief Operating Officer and Chief Financial Officer at Isarna Therapeutics GmbH, and he held leadership positions in marketing and product development at Biognostik Molecular Diagnostics GmbH.

Academic Background

Reimar holds an MD-PhD from the Georg-August-Universität Göttingen, where he also conducted post-doctoral research at the Max Planck Institute for Biophysical Chemistry.

Areas of Expertise

Reimar's areas of expertise include strategic business development, venture capital funding, pipeline portfolio management, and collaborative partnership formation. He has a deep understanding of the life sciences industry, with a particular focus on the development and commercialization of innovative pharmaceutical and medical technology solutions. Additionally, Reimar's leadership skills and interim management expertise have enabled him to guide companies through periods of transition and transformation.

Professional Impact

Throughout his career, Reimar has played a pivotal role in shaping the strategic direction of the organizations he has served. His ability to identify and capitalize on emerging market opportunities, coupled with his collaborative approach to stakeholder engagement, has resulted in significant achievements, such as securing substantial funding, forging strategic alliances, and advancing the development of cutting-edge therapeutics.

Conclusion

Reimar Schlingensiepen is a seasoned life sciences executive with a proven track record of driving growth, innovation, and success. His extensive industry expertise, combined with his strategic vision and leadership skills, make him a valuable asset to the companies he serves. As he continues to guide AudioCure Pharma GmbH and Themeos Interim Management and Business Development, Reimar remains committed to advancing the field of life sciences and creating lasting impact.